Identification of Novel Functional Inhibitors of Acid Sphingomyelinase https://t.co/ECzs0N1SYo https://t.co/TptHXZmf3U
The classification criterion used by Kornhuber et al. (https://t.co/iQ1z2jUlWf) was based on the observed bimodal distribution for the whole of analyzed drugs (n = 276) concerning functional inhibition of ASM. https://t.co/84pnFYcVl0
@NickytaLeb https://t.co/v4naqQKWku Oh, it's a FIASMA
@dimlabim @WIlliam53802832 I would imagine there are more than what are listed. But it’s a start. Here’s the link to Ref 1 https://t.co/AcWYaDoyXD
@DrDenaGrayson We’ve known about this for over a year https://t.co/8EBJSeOnv0
@DrDenaGrayson We knew about this for a year https://t.co/8EBJSeOnv0
@EricTopol @LancetGH People were talking about this in 2020...why does it take so long to hit mainstream!? https://t.co/8EBJSeOnv0
@boulware_dr @AngelaReiersen Wish people had listened last year - better late than never https://t.co/8EBJSeOnv0
@AngelaReiersen Thanks, @AngelaReiersen. I refer to the paper by Johannes Kornhuber et al. (You are part of the team) in which it is reported that citalopram has a residual activity of ASM greater than 50% (not FIASMA then?). So that is what I meant by my
RT @AngelaReiersen: Another possible mechanism of action for fluvoxamine and other SSRIs....
RT @AngelaReiersen: Another possible mechanism of action for fluvoxamine and other SSRIs....
Another possible mechanism of action for fluvoxamine and other SSRIs....
@a_chtung @farid__jalali @srrezaie @cameronks @VirusesImmunity @WesElyMD @gattinon @AngelaReiersen @ThinkingCC @Jeff_Browndyke @MarkOldhamMD @andymoz78 Yes some SSRIs also inhibit acid sphingomyelinase. Fluoxetine is notably one of them. https://t.co/PV3
#PLOSONE: Identification of Novel Functional Inhibitors of Acid Sphingomyelinase http://t.co/jgq0fah3cG